Application | Comment | Organism |
---|---|---|
medicine | peripheral administration of the cGMP-PDE inhibitor zaprinast dramatically alters the inflammatory response of astrocytes and microglia/macrophages to focal brain injury, decreases oxidative stress and neurodegeneration, and increases angiogenesis and vascular endothelial growth factor expression | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
zaprinast | - |
Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
3',5'-cGMP + H2O | Rattus norvegicus | - |
5'-GMP | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
3',5'-cGMP + H2O | - |
Rattus norvegicus | 5'-GMP | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cGMP phosphodiesterase | - |
Rattus norvegicus |
cGMP-PDE | - |
Rattus norvegicus |
PDE5 | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00013 | - |
pH and temperature not specified in the publication | Rattus norvegicus | zaprinast |